Lifeboat Foundation

Money manager BlackRock has invested $550 million in STRATOS, the world’s largest direct air capture facility.

Monumental raises $25M to advance construction robotics, addressing labor shortages and boosting productivity with AI-driven innovation.

AI startup OpenAI has unveiled a text-to-video model, called Sora, which could raise the bar for what’s possible in generative AI.

Like Google’s text-to-video tool Lumiere, Sora’s availability is limited. Unlike Lumiere, Sora can generate videos up to 1 minute long.

Text-to-video has become the latest arms race in generative AI as OpenAI, Google, Microsoft and more look beyond text and image generation and seek to cement their position in a sector projected to reach $1.3 trillion in revenue by 2032 — and to win over consumers who’ve been intrigued by generative AI since ChatGPT arrived a little more than a year ago.

A designer revealed an Infiniti-inspired QX90, a concept car that looks oddly similar to the Tesla Cybertruck with a few key differences.

Plant leaves come in many different shapes, sizes and complexities. Some leaves are large and smooth, while others are smaller and serrated. Some leaves grow in single pieces while others form multiple leaflets. These variations in leaf structure play a crucial role in how plants adapt—and survive—in different environments.

“Plant morphology is diverse in nature,” said Zhongchi Liu, a professor emerita in the University of Maryland’s Department of Cell Biology and Molecular Genetics. “Morphological differences contribute to plant survival, including how well plants can regulate their temperatures and how efficiently they can transport water from their roots to the rest of their bodies.

Understanding the mechanisms responsible for diverse leaf forms will lead to a better understanding of how plants can survive challenging conditions.

Episode NotesToday, Avi Loeb joins us to explore his work in discovering Alien Artifacts falling from space, evidence that Aliens exist, and the possibility…

SoftBank Group Chief Executive Officer Masayoshi Son is looking to raise up to $100 billion for a chip venture that will rival Nvidia Corp, Bloomberg News reported on Friday, citing people with knowledge of the matter.

Two RNA-editing therapies for genetic diseases have recently gained approval for clinical trials, raising hopes for safer treatments.

The challenge is huge: There’s a lot we don’t understand about Alzheimer’s disease, but we do know that patient’s brains tend to accumulate toxic tau and amyloid-beta proteins, so most research has focused on those targets.

That approach has led to new drugs that can slow the progression of Alzheimer’s to a small degree, but we’ve yet to find anything that can reverse the damage the disease does to the brain.

The big idea: Synapses — the connections between brain neurons — need a protein called “KIBRA” in order to form memories, and there’s a link between certain variants of the KIBRA gene and developing Alzheimer’s.